Маркетинговые исследования
Вы хотите отреагировать на этот пост ? Создайте аккаунт всего в несколько кликов или войдите на форум.
Поиск
 
 

Результаты :
 


Rechercher Расширенный поиск

Информация


Реклама
Создать форум
 

Do prosurvival BCL2 proteins lock Pandoras box Prosurvival BCL2 family proteins

Перейти вниз

 Do prosurvival BCL2 proteins lock Pandoras box Prosurvival BCL2 family proteins Empty Do prosurvival BCL2 proteins lock Pandoras box Prosurvival BCL2 family proteins

Сообщение  wangqian Пн Фев 10, 2014 12:45 pm

In a five year observation period of 10,309 DM2 patients, a significant reduction in cancer mortality was noted among those on metformin when compared to patients on sulfonylurea derivatives or insulin, esophageal, liver, colorectal, pan creatic, breast and lung cancers having the greatest Amuvatinib MP-470 risk reduction, Recent studies have showed that metfor min can inhibit cell proliferation and induce apoptosis in endometrial cancer cell lines, The mechanism of metformin action is complex, all processes ultimately lead to enhanced tissue insulin sensitivity and reductions in blood glucose and insulin levels. The basic mechanism of metformin is to activate serine threonine kinase, a key protein in sustain ing proper cell energy management.<br><br> Metformin activates AMPK indirectly via a suppressor protein, liver kinase B1, and via the activation of tuberous sclerosis complex 2 which inhibits the mammalian target Afatinib 価格 of rapamycin protein, one of the key proteins in regulating cell division, protein synthesis, growth and angiogenic processes, The mTOR protein is activated via the PI3K Act path way induced by insulin and growth factors : IGF 1, EGF, PDGF and VEGF. High levels of insulin and IGFs in patients with DM2 and EC are contributive to mTOR overexpression, increased cell proliferation and resistance to apoptosis, Additionally to the established role of estrogen and progesterone in hyperplasia induction and endometrial cancer onset, are other factors also involved in the development of this cancer, which include IGF 1R, B catenin and PAX 2. IGF 1 is a polypeptide produced in the liver similar in structure and function to insulin.<br><br> After binding to its receptor, signaling may occur through differ ent mediators, the dominant pathway being PI3K Akt, but also the MAPK pathway. In the uterus, IGF 1 expression is strictly regu lated AG-1478 ic50 by estrogen. Its signaling system is essential for cell differentiation, proliferation and migration. IGF 1 overexpression leads to neoplastic transformation, cancer progression and metastasis, While examining the expression of IGF 1R in 152 cancers of various sites of origin, Ouban et al. demonstrated high receptor membrane expression in breast cancer with prevalence of 87. 5%, and of the ovary and endometrium with prevalence of 100%. B Catenin with E cadherin play a role in preserving proper tissue architecture through the regulation of intercellular adhesion.<br><br> Moreover, it constitutes part of the Wnt pathway that participates in the control of the expression of genes responsible for the normal course of the cell cycle, as well as for proliferation and for apoptosis. Mutations leading to the Wnt pathways excessive activation, are found in many malignant neo plasms including EC. Numerous studies show that B catenin mutations may be crucial for carcinogenesis, Because the studies evaluating B catenin expres sion in the presence of DM2 are limited, we have decided to investigate if DM2 and its method of treatment change the role of B catenin in EC. The PAX 2 gene encodes the transcript proteins in volved in cell proliferation, differentiation and apoptosis.

wangqian

Количество сообщений : 120
Дата регистрации : 2013-11-28

Вернуться к началу Перейти вниз

Вернуться к началу

- Похожие темы

 
Права доступа к этому форуму:
Вы не можете отвечать на сообщения